{"id":9492,"date":"2026-02-16T17:31:59","date_gmt":"2026-02-16T09:31:59","guid":{"rendered":"https:\/\/regask.com\/?p=9492"},"modified":"2026-02-16T17:31:59","modified_gmt":"2026-02-16T09:31:59","slug":"la-tga-de-australia-actualiza-la-guia-sobre-software-de-dispositivos-medicos-con-ia-y-los-requisitos-de-evidencia-de-artg","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/","title":{"rendered":"La TGA de Australia actualiza la gu\u00eda sobre desarrollo m\u00e9dico con IA\u2026"},"content":{"rendered":"<p>En <strong>5 de febrero de 2026<\/strong>, el <strong>Administraci\u00f3n de Productos Terap\u00e9uticos (TGA)<\/strong> public\u00f3 una gu\u00eda actualizada que aclara c\u00f3mo <strong>software habilitado con inteligencia artificial<\/strong> Est\u00e1 regulado como dispositivo m\u00e9dico en Australia. La actualizaci\u00f3n afecta a las organizaciones que desarrollan, suministran o mantienen software de dispositivos m\u00e9dicos basado en IA y define expectativas m\u00e1s claras para la clasificaci\u00f3n regulatoria, la generaci\u00f3n de evidencia y la gesti\u00f3n del ciclo de vida.<\/p>\n<div class=\"row\"  id=\"row-1866287129\">\n\n\t<div id=\"col-927365309\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-575664855\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-575664855 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Detalles de la actualizaci\u00f3n<\/h2>\n\t<div id=\"gap-376922021\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-376922021 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La gu\u00eda actualizada aclara que <strong>El software habilitado con IA se regula como un dispositivo m\u00e9dico en funci\u00f3n de su prop\u00f3sito previsto,<\/strong> Independientemente de la tecnolog\u00eda subyacente o la plataforma de entrega. Software dise\u00f1ado para <strong>diagn\u00f3stico, seguimiento o tratamiento<\/strong> debe estar incluido en el <strong>Registro Australiano de Productos Terap\u00e9uticos (ARTG)<\/strong> antes de que pueda suministrarse en Australia.<\/p>\n<p>La gu\u00eda explica las obligaciones de los fabricantes para gestionar <strong>actualizaciones de software y ampliaci\u00f3n del alcance,<\/strong> destacando que los cambios que alteran el uso o el rendimiento previstos pueden generar la necesidad de <strong>aprobaci\u00f3n regulatoria antes de su lanzamiento.<\/strong> Tambi\u00e9n aborda <strong>uso fuera de etiqueta,<\/strong> indicando que cuando se detecta dicho uso, los fabricantes est\u00e1n obligados a restringirlo o buscar la inclusi\u00f3n de ARTG para la nueva indicaci\u00f3n.<\/p>\n<p>En relaci\u00f3n con la generaci\u00f3n de evidencia, la TGA aclara las expectativas para <strong>datos sint\u00e9ticos,<\/strong> se\u00f1alando que si bien puede utilizarse para complementar la evidencia cl\u00ednica, <strong>No puede reemplazar los datos cl\u00ednicos del mundo real.<\/strong> Cuando se utilizan datos sint\u00e9ticos para la validaci\u00f3n, los fabricantes deben documentar tanto <strong>Justificaci\u00f3n de su uso<\/strong> y el<strong> m\u00e9todos utilizados para generarlo.\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-927365309 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1816635712\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Fecha de entrada en vigor<\/h2>\n\t<div id=\"gap-175455368\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-175455368 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La gu\u00eda actualizada de la TGA sobre el software de dispositivos m\u00e9dicos habilitado con IA se aplica a partir de <strong>5 de febrero de 2026. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1816635712 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-554992455\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Por qu\u00e9 es importante<\/h2>\n\t<div id=\"gap-935631333\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-935631333 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Esta actualizaci\u00f3n proporciona mayor claridad regulatoria sobre c\u00f3mo se eval\u00faa, mantiene y evidencia el software de dispositivos m\u00e9dicos basado en IA a lo largo de su ciclo de vida. Al establecer expectativas m\u00e1s claras en torno a las tecnolog\u00edas de salud digital, la gesti\u00f3n de actualizaciones y los est\u00e1ndares de evidencia, la gu\u00eda promueve una alineaci\u00f3n regulatoria m\u00e1s consistente, a la vez que busca reducir la incertidumbre y la carga innecesaria de cumplimiento para las partes interesadas reguladas.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-554992455 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1924054064\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Para qui\u00e9n es relevante<\/h2>\n\t<div id=\"gap-1051240894\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1051240894 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La gu\u00eda es relevante para asuntos regulatorios, garant\u00eda de calidad, seguridad del paciente, legales y de cumplimiento, comerciales y de marketing, y equipos de I+D involucrados en el desarrollo y la gesti\u00f3n del ciclo de vida del software de dispositivos m\u00e9dicos basado en IA en Australia.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1924054064 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-326982817\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pr\u00f3ximos pasos<\/h2>\n\t<div id=\"gap-124579933\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-124579933 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Las organizaciones deben revisar los productos de software habilitados para IA actuales y en desarrollo para confirmar la alineaci\u00f3n con los requisitos aclarados. <strong>Criterios de inclusi\u00f3n de ARTG<\/strong> y expectativas de documentaci\u00f3n. Procesos internos para la gesti\u00f3n <strong>actualizaciones de software<\/strong> y <strong>detecci\u00f3n de uso fuera de etiqueta<\/strong> deben evaluarse para garantizar que cumplan con las directrices actualizadas y las estrategias de evidencia deben revisarse cuando sea necesario. <strong>datos sint\u00e9ticos<\/strong> Se utiliza en la validaci\u00f3n.<\/p>\n<p>A medida que las expectativas regulatorias para los dispositivos m\u00e9dicos impulsados por IA contin\u00faan evolucionando, mantenerse a la vanguardia de las actualizaciones de las directrices es fundamental. <strong><a href=\"http:\/\/regask.com\/es\/\">RegASK<\/a> Es una plataforma l\u00edder de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con IA agentic que permite a organizaciones globales en sectores altamente regulados, como productos de consumo y ciencias de la vida, gestionar de forma proactiva entornos regulatorios complejos. Al combinar IA agentic avanzada con expertos en el sector, <a href=\"http:\/\/regask.com\/es\/\">RegASK<\/a><\/strong> <strong>Proporciona informaci\u00f3n predictiva y procesable oportuna y automatizaci\u00f3n de extremo a extremo, agilizando los procesos de cumplimiento, mitigando riesgos y acelerando el acceso al mercado en m\u00e1s de 160 pa\u00edses.<\/strong> <a href=\"http:\/\/regask.com\/es\/\"><strong>M\u00e1s informaci\u00f3n<\/strong><\/a> o <a href=\"https:\/\/regask.com\/es\/\"><strong>Reserve una demostraci\u00f3n ahora.\u00a0<\/strong><\/a><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-326982817 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-667994184\">\n\n\t<div id=\"col-1729631946\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>Preguntas frecuentes<\/h3>\n\t<div id=\"gap-1570877391\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1570877391 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4>\u00bfCu\u00e1ndo se regula el software habilitado con IA como dispositivo m\u00e9dico en Australia?<\/h4>\n\t<div id=\"gap-1299564784\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1299564784 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El software habilitado con IA se regula como un dispositivo m\u00e9dico cuando su <strong>prop\u00f3sito previsto<\/strong> es para diagn\u00f3stico, seguimiento o tratamiento, independientemente de la tecnolog\u00eda o plataforma utilizada.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1729631946 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-2066666771\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u00bfEs necesaria la inclusi\u00f3n de ARTG para el software de dispositivos m\u00e9dicos basado en IA?<\/h4>\n\t<div id=\"gap-508681384\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-508681384 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>S\u00ed. El software habilitado con IA destinado al diagn\u00f3stico, monitoreo o tratamiento debe estar incluido en el <strong>ARTG antes del suministro<\/strong> en Australia.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2066666771 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1588024495\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u00bfPueden los datos sint\u00e9ticos sustituir a la evidencia cl\u00ednica seg\u00fan las directrices actualizadas?<\/h4>\n\t<div id=\"gap-390422587\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-390422587 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>No. Los datos sint\u00e9ticos pueden <strong>complementan pero no reemplazan la evidencia cl\u00ednica,<\/strong> y su uso debe estar justificado y documentado.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1588024495 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-553742105\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u00bfC\u00f3mo puede RegASK ayudar a los equipos que gestionan el cumplimiento normativo de los dispositivos m\u00e9dicos con inteligencia artificial?<\/h4>\n\t<div id=\"gap-1227360754\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1227360754 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><a href=\"http:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a> ayuda a las organizaciones a realizar un seguimiento de actualizaciones regulatorias como esta gu\u00eda de TGA, evaluar el impacto en las carteras de productos y coordinar respuestas de cumplimiento utilizando informaci\u00f3n impulsada por IA combinada con supervisi\u00f3n regulatoria experta.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-553742105 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On February 5, 2026, the Therapeutic Goods Administration (TGA) published updated guidance clarifying how artificial intelligence enabled software is regulated as a medical device in Australia. The update affects organizations developing, supplying, or maintaining AI-driven medical device software and outlines clearer expectations for regulatory classification, evidence generation, and lifecycle management.<\/p>","protected":false},"author":43,"featured_media":9493,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,511,39],"tags":[],"class_list":["post-9492","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-australia-regulations","category-medical-devices-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Australia TGA Updates Guidance on AI-Enabled Devices<\/title>\n<meta name=\"description\" content=\"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/la-tga-de-australia-actualiza-la-guia-sobre-software-de-dispositivos-medicos-con-ia-y-los-requisitos-de-evidencia-de-artg\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Australia TGA Updates Guidance on AI-Enabled Medical Device Software and ARTG Evidence Requirements\" \/>\n<meta property=\"og:description\" content=\"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/la-tga-de-australia-actualiza-la-guia-sobre-software-de-dispositivos-medicos-con-ia-y-los-requisitos-de-evidencia-de-artg\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T09:31:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\" \/>\n\t<meta property=\"og:image:width\" content=\"904\" \/>\n\t<meta property=\"og:image:height\" content=\"622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Australia TGA Updates Guidance on AI-Enabled Medical De&hellip;\",\"datePublished\":\"2026-02-16T09:31:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\"},\"wordCount\":776,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"articleSection\":[\"Regulatory News\",\"Australia\",\"Medical Devices\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\",\"name\":\"Australia TGA Updates Guidance on AI-Enabled Devices\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"datePublished\":\"2026-02-16T09:31:59+00:00\",\"description\":\"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"width\":904,\"height\":622,\"caption\":\"Australia Tga Updates Guidance Ai Enabled Medical Device Software Artg Evidence Requirements\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La TGA de Australia actualiza la gu\u00eda sobre dispositivos con inteligencia artificial","description":"La TGA de Australia actualiza la gu\u00eda sobre el software de dispositivos m\u00e9dicos habilitado con IA, aclarando los requisitos de evidencia de ARTG para los fabricantes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/la-tga-de-australia-actualiza-la-guia-sobre-software-de-dispositivos-medicos-con-ia-y-los-requisitos-de-evidencia-de-artg\/","og_locale":"es_ES","og_type":"article","og_title":"Australia TGA Updates Guidance on AI-Enabled Medical Device Software and ARTG Evidence Requirements","og_description":"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.","og_url":"https:\/\/regask.com\/es\/la-tga-de-australia-actualiza-la-guia-sobre-software-de-dispositivos-medicos-con-ia-y-los-requisitos-de-evidencia-de-artg\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-02-16T09:31:59+00:00","og_image":[{"width":904,"height":622,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#article","isPartOf":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Australia TGA Updates Guidance on AI-Enabled Medical De&hellip;","datePublished":"2026-02-16T09:31:59+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/"},"wordCount":776,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","articleSection":["Regulatory News","Australia","Medical Devices"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/","url":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/","name":"La TGA de Australia actualiza la gu\u00eda sobre dispositivos con inteligencia artificial","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","datePublished":"2026-02-16T09:31:59+00:00","description":"La TGA de Australia actualiza la gu\u00eda sobre el software de dispositivos m\u00e9dicos habilitado con IA, aclarando los requisitos de evidencia de ARTG para los fabricantes.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","width":904,"height":622,"caption":"Australia Tga Updates Guidance Ai Enabled Medical Device Software Artg Evidence Requirements"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=9492"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9492\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/9493"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=9492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=9492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=9492"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}